How cancer stem cell exosomes fuel tumor growth and evade immune attack

A new editorial paper was published in Oncotarget’s Volume 14 on December 20, 2023, entitled, “Therapeutically harnessing cancer stem cell-derived exosomes.”

Digital twins: A new path to personalised medicine – Pharmaceutical Technology

Many healthcare professionals have long seen the potential of personalised medicine to revolutionise the industry by understanding patients’ unique needs and providing them with the

October 15, 2024

Sionna raises $182m to double down in cystic fibrosis drug development – Pharmaceutical Technology

Share this article The round secures funding for the company through 2026. Image credit: Shutterstock/OlekStock. Sionna Therapeutics has continued raising capital, closing a $182m Series

March 7, 2024

Dexcom, Hologic picked to outperform in 2024: William Blair

Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: William Blair analysts have selected

December 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.